|title=Mesothelioma Molecular and Genetic Testing: BAP1, CDKN2A, NGS Panels & Biomarker-Guided Treatment
|description=Comprehensive guide to molecular and genetic testing for mesothelioma including BAP1 mutations, CDKN2A FISH, NF2 inactivation, n
...
55 KB (7,206 words) - 22:37, 8 March 2026
...center; font-style:italic; border-bottom:1px solid #dee2e6;" | Blood-Based Diagnostic and Monitoring Tests
| style="padding:10px; border-bottom:1px solid #dee2e6;" | Medical / Diagnostic
...
38 KB (4,844 words) - 09:56, 6 April 2026
...-style:italic; border-bottom:1px solid #dee2e6;" | Prediagnostic Biomarker Testing for Mesothelioma
| style="padding:10px; border-bottom:1px solid #dee2e6;" | Medical / Diagnostic
...
39 KB (5,116 words) - 10:12, 6 April 2026
|title=Mesothelioma Biopsy Procedures: Techniques, Accuracy Rates, and Diagnostic Pathways
| style="padding:10px; border-bottom:1px solid #dee2e6;" | Diagnostic / Medical
...
60 KB (7,892 words) - 10:12, 6 April 2026
|keywords=mesothelioma misdiagnosis, mesothelioma misdiagnosed, mesothelioma diagnostic delay, mesothelioma vs adenocarcinoma, peritoneal mesothelioma ovarian canc
...y '''20%''', compared to roughly '''8%''' for distant disease — a gap that diagnostic delay meaningfully widens by moving patients from stage I–II into stage III
...
39 KB (5,209 words) - 16:36, 6 April 2026
...logical subtypes, TNM 8th edition staging, blood biomarkers, and molecular testing.
...text-align:center; font-style:italic; border-bottom:1px solid #dee2e6;" | Diagnostic Workup & Staging Overview
...
58 KB (7,640 words) - 09:56, 6 April 2026
...ide to paracentesis and thoracentesis for mesothelioma patients — covering diagnostic fluid analysis, cytology sensitivity (45.1%), BAP1/MTAP biomarkers, ultraso
...ing:10px; border-bottom:1px solid #dee2e6;" | Needle-based fluid drainage (diagnostic and therapeutic)
...
69 KB (8,827 words) - 10:21, 6 April 2026
* Fiber composition (tremolite/anthophyllite) serves as diagnostic fingerprint for cosmetic talc exposure in tissue analysis<ref name="emory20
Research by Gordon et al. (2014) documented both exposure routes in detail. Testing of factory-sealed Cashmere Bouquet containers spanning five decades found a
...
26 KB (3,341 words) - 02:39, 21 February 2026
=== Diagnostic Imaging ===
...ame="pmc4754312" /> Paracentesis and cytology of ascitic fluid has limited diagnostic yield and is not recommended as a sole approach.<ref name="pmc5674249" />
...
30 KB (3,699 words) - 01:11, 6 April 2026
...in Biomarker Accuracy''' || 61% sensitivity, 87% specificity; FDA-approved diagnostic marker<ref name="biomarkerdata" />
...s) to rapidly fatal malignancies (mesothelioma). Each disease has distinct diagnostic criteria, prognosis, and clinical features.<ref name="mlc" /> The following
...
43 KB (5,354 words) - 03:51, 9 March 2026
...of the tunica vaginalis testis covering epidemiology, asbestos causation, diagnostic workup, radical orchiectomy, adjuvant therapy, survival paradox, and legal
...expected, often provoking surprise even among experienced urologists. This diagnostic challenge is compounded by the fact that standard testicular tumor markers
...
50 KB (6,417 words) - 09:57, 6 April 2026
...ontamination and occupational asbestos exposure. Quality control personnel testing pharmaceutical batches in filtration verification operations encountered di
...sbestos in hospital gauze pads; 35-45% chrysotile in beaker tongs (product testing data)<ref name="mesoattorney-talc" />
...
43 KB (5,185 words) - 09:18, 6 April 2026
...efit from aggressive surgical treatment. His work on the "four-gene ratio" diagnostic test opened pathways for personalized treatment planning based on tumor mol
| style="padding:10px;" | '''Molecular Diagnostic'''
...
28 KB (3,556 words) - 10:12, 6 April 2026
* '''Implications for Latency and Litigation:''' Genetic testing for BAP1 mutations is increasingly available and relevant to mesothelioma c
...invasive cancer is diagnosed. This frontier of latency research opens both diagnostic and legal opportunities.<ref name="pleuralplaques" /><ref name="shortlatenc
...
53 KB (7,014 words) - 22:37, 8 March 2026
...dose CT screening protocols, DOE Former Worker Program outcomes, biomarker testing, and international screening program results.
...d be performed at least every 2 years for all exposed workers, with annual testing required for those with 10 or more years of asbestos exposure history or th
...
50 KB (6,457 words) - 09:18, 6 April 2026
...page provides a comprehensive overview of mesothelioma's causes, symptoms, diagnostic process, treatment options, and the full range of legal compensation pathwa
| style="padding:10px;" | '''ASCO 2025 Universal Germline Testing'''
...
62 KB (7,831 words) - 01:11, 6 April 2026
| style="padding:10px; border-bottom:1px solid #dee2e6;" | '''BAP1 Loss as Diagnostic Marker'''
...as pneumonia, chronic obstructive pulmonary disease, or lung cancer. This diagnostic ambiguity frequently results in delays of '''3 to 6 months''' between initi
...
59 KB (7,425 words) - 01:11, 6 April 2026
...stemic toxicity — a critical consideration for early-phase clinical safety testing.<ref name="pmcpotential" /><ref name="pubmedsterman98" />
...mal outlook provided both clinical rationale and ethical justification for testing novel and unproven therapeutic approaches in affected patients.<ref name="p
...
67 KB (8,763 words) - 09:18, 6 April 2026
* Comprehensive diagnostic services including advanced imaging
Research into molecular testing that may help determine prognosis and guide treatment decisions.
...
30 KB (3,597 words) - 14:57, 9 March 2026
...ns''' — patients seen by listed specialists gain access to 6 active trials testing CAR T-cell therapy, neoadjuvant immunotherapy, and gene therapy unavailable
...s authored over 400 peer-reviewed articles spanning mesothelioma genomics, diagnostic biomarkers, and surgical innovations. In 2013, he performed the first image
...
63 KB (8,220 words) - 22:37, 8 March 2026
